Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Polish Researchers Cite Rutherrin PDT for Brain Cancer

<< Previous

Bullboard Posts

Next >>

Comment by Lesalpes29on Sep 13, 2023 6:50am

242 Views

Post# 35633191

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Polish Researchers Cite Rutherrin PDT for Brain Cancer

Yes Dawg it's a deception to see where we stand after all the good results and the science behind. The time to find a partner with money is probably now. Running on fume is not confortable for longs like most here. Maybe ower management now understand they can't continue like this. GL

<< Previous

Bullboard Posts

Next >>

Nvidia reports record revenue in Q3